Objective: To assess the correlation of tissue parameters estimated by quantitative magnetic resonance (MR) techniques and motor handicap in patients with hypomyelination.
Quantitative magnetic resonance (MR) techniques provide information on histopathology of brain white matter (WM) disorders. [1] [2] [3] [4] [5] [6] [7] [8] [9] In this study, we focused on hypomyelinating disorders, defined by permanent lack of myelin deposited. Hypomyelination can be diagnosed by MRI based on a pattern of mildly hyperintense T2 signal ( figure 1A) and mildly hypo-, iso-, or hyperintense T1 signal of the WM relative to the cortex (figure 1B), depending on myelin content. 10 Follow-up MRI at least 6 months later and at an age older than 1 or preferably 2 years should show no myelination progress. 10 Clinically, hypomyelination is associated with variable handicap ranging from walking without support and attending regular school to wheelchair dependency and absence of speech. 11 The variation in handicap is unexplained; conventional MRI does not show clear differences in myelin content. These observations bring into question the relative importance of myelin, especially compared to axonal integrity. Such questions are fundamental when considering therapies that are aimed at promotion of myelination. 12 Previous studies of quantitative MR in hypomyelination showed that hypomyelinating disorders are generally characterized by results that are close to normal. 6, 8 In the present study, we aimed to assess the correlation of tissue measures as estimated by quantitative MR techniques and degree of motor handicap in patients with hypomyelination with the hypothesis that the myelin content, estimated by quantitative MRI measures, codetermines the severity of handicap. We included axial diffusivity (AD) and radial diffusivity (RD) because AD was found to correlate with axonal integrity 13, 14 and RD with intactness of myelin. 15, 16 METHODS Standard protocol approvals, registrations, and patient consents. This prospective case-control study was performed with approval of the institutional review board and consent of patients and/or parents.
Participants. Between January 2007 and June 2011, 28 patients (table 1) underwent MRI, who fulfilled the following inclusion criteria: (1) DNA-proven hypomyelinating disorder, or (2) stable substantial deficit in myelination on 2 consecutive MRIs with an interval of at least 6 months and the second MRI in the second year or later, or (3) severe deficit in myelination on MRI in a child older than 2 years, making it unlikely that normal myelination will ever be achieved. 10 Four of these 28 patients had 2 quantitative MRIs during this period. The best quality and most complete MRI was used for analysis; if the quality was equal, the first was chosen. Using this strategy, the first MRI was analyzed in 2 cases and the second in the other two. Experienced investigators (N.I.W., M.S.v.d.K.) visually rated the MRI scans. Twelve patients were male, 16 were female; age range was 0.5 to 47 years (mean age 6 SD: 11.4 6 9.9 years). None of the patients had other coexistent conditions that might affect the brain WM. To obtain normative data, we included 61 individuals in the same age range who underwent MRI for other reasons (mild developmental delay, autism, epilepsy, tics, headache) and had a normal MRI and neurologic examination. Thirty-three were male, 28 female; age range was 0.3 to 44 years (mean age 6 SD: 7.9 6 9.4 years). Some control participants underwent only part of the quantitative MRI protocol (table e-1 on the Neurology ® Web site at Neurology.org).
MR acquisition. All studies were conducted on the same MR machine at 1.5T (Siemens Sonata, Erlangen, Germany) with an 8-channel phased-array head coil. The conventional imaging protocol included axial T2-weighted spin echo images, axial fluidattenuated inversion recovery images, and sagittal T1-weighted images using a 3-dimensional magnetization-prepared rapidacquisition gradient echo sequence.
For MR spectroscopy with chemical shift imaging (CSI), we used PRESS (point-resolved spectroscopy) (repetition time [TR]/ echo time [TE] 3,000/30 milliseconds [ms], 6 acquisitions with weighted phase encoding) on a single 15-mm slice (field of view 120-160 3 160 mm 2 depending on head size, volume of interest 60-80 3 100 mm 2 , 16 3 16 phase encodings, voxel size 7.5-10 3 10 3 15 mm 3 ) centered onto the corpus callosum. Unsuppressed water reference scans were obtained with head and body coil. 17 For diffusion tensor imaging (DTI), we used a multislice echo planar imaging sequence (TR/TE 6,700/81 ms, b value 750 s/mm 2 , 12 directions, 2 acquisitions, 1 b0 volume, 49 slices, pixel size 2.5 3 2.5 3 2.5 mm 3 , no parallel imaging). One of the slices corresponded to the center of the CSI slice.
For T2 relaxometry, we used a Carr-Purcell-Meiboom-Gill sequence to acquire images at 32 different echo times (TR 2,500 ms, TE 10.4-332.8 ms, spacing 10.4 ms, 5 slices, pixel Data processing and analysis. We quantified metabolite concentrations measured by CSI as described before using LCModel 18 ; metabolite concentrations were reported in millimole/liter. For generation of pixel-wise T2 maps, we fitted the relaxation time curves to a mono-exponential decay: S(t) 5 S(0) exp(2t/T2). We created magnetization transfer ratio (MTR) maps according to the equation MTR 5 1 2 (M s /M 0 ). We used the FMRIB Software Library (http://www.fmrib.ox.ac.uk/fsl) to analyze DTI data, resulting in maps of fractional anisotropy (FA), AD, RD, and mean diffusivity (MD) (or apparent diffusion coefficient). FA images from multiple participants were aligned into a common space with tract-based spatial statistics (TBSS) and a mean FA skeleton was created. Each participant's aligned FA data were projected onto this skeleton and fed into voxel-wise cross-participant statistics using Randomize, with age as covariate. 19 We estimated DTI measures and T2 and MTR values in 3 WM regions of interest (ROIs), representing different phases during normal myelination: early myelination (corticospinal tracts in the centrum semiovale), intermediate myelination (splenium), and late myelination (parietal deep WM). The advantage of including the splenium is that it does not contain fibers with different orientations ("crossing fibers"). DTI ROIs, positioned in standard space, were identical for all participants. We manually placed ROIs on T2 and MTR maps based on visual matching with DTI ROIs. In some patients, the splenium was very thin, hampering ROI positioning (table e-1). Regarding CSI, we included voxels in the analyses that best corresponded to the parietal deep WM ROIs, as well as voxels containing the corticospinal tracts. The splenium of the corpus callosum was not present in the CSI slab and therefore not included. Values of left and right hemispheres were averaged. Using TBSS, we further evaluated DTI measures by estimating the percentage of the WM skeleton that was significantly different from controls (threshold-free cluster enhancement [TFCE]-corrected p , 0.01). For the voxels, in which all DTI metrics were significantly different between patient and control values, we extracted the DTI values and averaged them for patients and controls.
Motor handicap. Because there is no standardized tool to assess motor performance in hypomyelinating disorders, we used the quantitative, validated, and widely used gross motor function classification system (GMFCS) 20 to score the severity of motor handicap at the time of MRI to allow comparison of motor function with quantitative MR measures. Two experienced investigators (M.E.S., N.I.W.) separately assessed patients based on medical files.
To evaluate the correlation between GMFCS and quantitative MR measures, we used the parietal deep WM ROI and the ROI containing the corticospinal tracts in the centrum semiovale.
Statistical analysis. We constructed 3 datasets, one comprising patient values, a second containing control values, and a third with calculated control values age-matched per patient, based on a mono-exponential fit through the control measures: a 1 b exp(2age/tau). Parameters a (limiting value), b (difference between limiting value and value at age 0 years), and tau (time constant) were estimated using nonlinear least squares (table e-2).
To assess whether the MR measures were significantly different between patients and controls, we first removed the dependency on age by subtraction of an isotonic regression curve fitted jointly (as appropriate under the null hypothesis) on both groups. Subsequently, we used the Wilcoxon rank sum test to compare the resulting age-corrected characteristics (residuals) of the 2 groups.
To evaluate a possible distinction between AD and RD, we transformed the data of patients and controls to rank data followed by fitting of an isotonic regression curve between the rank data and age and obtaining the residual ranks from this analysis. We used the Wilcoxon test to assess the significance of differences between AD and RD.
We used linear regression analyses to correlate GMFCS and quantitative MR measures. Missing MR measure data of patients Abbreviations: 4H 5 hypomyelination with hypogonadotropic hypogonadism and hypodontia; GMFCS 5 gross motor function classification system; HABC 5 hypomyelination with atrophy of the basal ganglia and cerebellum; HCC 5 hypomyelination with congenital cataract; ODDD 5 oculodentodigital dysplasia; PMD 5 Pelizaeus-Merzbacher disease; PMLD 5 PMD-like disease; RARS 5 hypomyelination with RARS mutations.
were imputed using a nonparametric k-nearest neighbor method. 21 First analysis comprised simple linear regression linking handicap to individual measures. Subsequently, we built a multiple linear regression model with a preference of the more parsimonious model. Model search was performed in a backward manner, first including all explanatory variables and then removing them one by one. We used selection frequency, based on application of lasso regression to 1,000 resampled versions of the dataset, as an inclusion criterion; cross-validation determined the lasso penalty measure. We chose the final model to minimize the number of explanatory variables without compromising the coefficient of determination.
RESULTS Table e -1 presents the number of included MR studies per quantitative method. Figure 1 shows examples of the FA, RD, MTR map, T2 map, and CSI spectrum. In the ROI analysis, FA was lower in patients than in controls in all areas. Regional distribution was similar in patients and controls: FA of the splenium was higher than that of the other WM areas. The decrease in FA in patients relative to age-matched controls was also largest in the splenium. AD, RD, and MD were higher in patients than in controls. Patients had the highest values of AD, RD, and MD in the splenium, and differences for these measures compared with controls were also largest in the splenium (figure e-1, table 2). When AD and RD were compared, the increase in RD was significantly greater relative to age-matched control values than the increase in AD (Wilcoxon rank sum test: p 5 0.008 for splenium; p 5 0.027 for corticospinal tracts in the centrum semiovale; p 5 0.002 for deep parietal WM). In all WM areas, MTR values were lower in patients than in controls (figure e-1, table 2), while T2 values were higher. For the TBSS analysis, we created a mean WM skeleton, shown in green in figure 2. When we compared DTI measures of patients with those of controls within the skeleton, extensive changes in all DTI measures were observed. FA was lower in patients than in controls in as much as 96% of the whole skeleton (TFCE-corrected threshold ,0.01). RD was increased in 93% of the skeleton, and MD in 84% of the skeleton. AD was increased in only 20% of the skeleton. These latter areas were confined to the splenium, small part of the genu, corona radiata, parts of the superior longitudinal fasciculus, and parts of the thalamic radiation (figure 2, D-F). Table 3 shows mean values of the measures within the area that was significantly abnormal for all DTI metrics (20% of the skeleton; TFCE-corrected threshold ,0.01). Although all voxels within this area had significantly increased AD, the relative increase in AD of 13% was much smaller than the 35% increase 
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Chemical shift imaging. CSI results were similar for the parietal deep WM and corticospinal tracts in the centrum semiovale. Choline (Cho)-containing compounds were lower and myo-inositol (Ins) was higher in patients than in controls. N-acetylaspartate, including N-acetylaspartylglutamate (NAA), and creatine (Cr) and phosphocreatine (Cr) mainly showed decreases and increases, respectively (figure e-1, table 2). To correct for possible effects of higher axonal density per tissue volume caused by lower density of myelin sheaths on NAA values, we also evaluated the ratio NAA/Cr. NAA/Cr values were either normal or reduced in patients compared with controls (figure e-1). DISCUSSION Our aim was to gain insight into tissue measures that account for unexplained variability in motor handicap among patients with hypomyelination, which could serve to monitor future therapies. The changes we found in quantitative MR measures in the WM are in line with lack of myelin, with low FA, high RD and AD, high T2 relaxation times, low MTR, and low Cho, and to a lesser degree with compromised axonal integrity with slightly elevated AD and decreased NAA/Cr. The variation in GMFCS was in part (58%) explained by the measures obtained in the parietal deep WM; the results for the area containing the corticospinal tracts were similar. Individually, RD, NAA/Cr, MTR, and T2 all correlated with GMFCS; NAA/Cr and RD were the strongest independent predictors.
Measurements of AD and RD in hypomyelination have not been reported previously. RD has been suggested to correlate with amounts and integrity of myelin 15, 16 and AD with axonal integrity. 13, 14 Because the interpretation of AD and RD in crossing fiber regions requires caution, 22 we also included the splenium. RD had the strongest correlation with GMFCS; AD showed a much weaker correlation. The increase in RD was larger and much more widespread than the change in AD (93% vs 20% of the skeleton), with a normal AD in large areas in which Abbreviations: AD 5 axial diffusivity; DTI 5 diffusion tensor imaging; FA 5 fractional anisotropy; MD 5 mean diffusivity; MR 5 magnetic resonance; RD 5 radial diffusivity. Data represent mean (SD) or mean. MR measures were significantly different between patients and controls at a threshold-free cluster enhancement-corrected threshold ,0.01.
conventional images indicate lack of myelin. DTI measures in the splenium were distinct from DTI measures in the other WM regions in that the differences between patients and controls were larger. Partial volume effects with inclusion of CSF in the ROIs may explain these findings, as in many patients the splenium had reduced thickness. Partial volume correction by the method of free water elimination might reduce this problem in future studies. 23, 24 MTR has been interpreted as a measure representing myelin integrity, although it has also been correlated with axonal integrity. 25 In our study, MTR alone correlated strongly with GMFCS, but was not selected as an independent explanatory variable. MTR is correlated with RD and NAA/Cr, and in the regression analysis, the combination of these latter 2 variables yielded the most parsimonious model without a significant extra contribution of MTR.
NAA was low to normal in the WM of patients. NAA, although synthesized and degraded in glia, is mainly located in neurons and axons and is a useful surrogate marker for axonal integrity and density. 26, 27 The relatively normal NAA in some patients could be interpreted as evidence of relative axonal integrity, but the explanation is more complex. High WM concentrations of NAA have been reported before in hypomyelination, 28 probably reflecting higher axonal density in the absence of normal myelin density. Dividing NAA by Cr, reflecting cell density in general, corrects at least partially for higher compaction due to lack of myelin. Whereas NAA and Cr individually did not correlate with the GMFCS, NAA/Cr did, suggesting that axonal damage does contribute to the motor handicap in hypomyelinating disorders, although to a lesser degree than lack of myelin considering the relatively small change in AD.
The above results are in line with existing evidence that RD is correlated inversely with amount and integrity of myelin and indicate that myelin is a stronger determiner of handicap in patients with hypomyelination than axonal integrity.
All odds were against this study with a rather small number of patients, heterogeneous diagnoses each associated with private effects on handicap and MR measures, large patient age variation, acquisition of quantitative MR measures in only 3 brain areas, and the neurologic health of controls not being fully guaranteed. Hypomyelinating disorders are very rare diseases with many different known and often unknown causes. 10, 29 A group of 28 patients investigated on one MR system is actually large. Ideally, only healthy participants would be included as controls, but this is not an option for very young children who need anesthesia or sedation. Despite normal neurologic examination and MRI, the controls had some complaints and their quantitative measures were probably more variable than in completely healthy participants.
The fact that we did find a correlation between quantitative MR measures and the severity of motor handicap despite these odds corroborates the results. Because we found this correlation in a group of hypomyelinating disorders with different causes and underlying pathologies, it is likely that the correlation would be even stronger in studies on single hypomyelinating disorders. That we found this correlation while comparing patients with control subjects with some neurologic complaints indicates that the correlation may actually be stronger. The correlation between quantitative brain MR measures and clinical handicap was found, while only 3 brain areas were investigated. If more areas, especially brainstem and spinal cord tracts would be included, the correlation would increase. Future longitudinal studies including more extensive serial MRI measurements and clinical follow-up should give the opportunity to further support the results of the present cross-sectional study.
Hypomyelinating disorders constitute a large fraction of the leukodystrophies, for which therapies are urgently needed. The fact that measures representing myelin integrity (RD) show a stronger correlation with motor handicap than measures of axonal integrity (NAA/Cr, AD) is a highly promising finding in view of strategies aimed at promotion of myelination. Objective measures to evaluate the success of novel therapies, such as neural stem cell engraftment, 30 are necessary. Our study indicates that quantitative MR can be useful to monitor outcome.
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